If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptima Health Regulatory News (OPT)

Share Price Information for Optima Health (OPT)

Share Price is delayed by 15 minutes
Get Live Data
191.00    0.00 (0.00%)
Bid:
190.00
Ask:
192.00
Spread: 2.00 (1.053%)
Market Cap: £207.76m
OPT Live PriceLast checked at - London Stock Exchange

Intraday Optima Health Share Chart

Full Year Trading Update

17 Apr 2026 07:00

RNS Number : 9162A
Optima Health PLC
17 April 2026
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

17 April 2026

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

Full Year Trading Update

Full year adjusted EBITDA expected to be c.10% ahead of market expectations

Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, today announces an unaudited trading update for the year ended 31 March 2026.

Further to the previously communicated commentary on current trading announced on 31 March 2026, Optima now expects FY26 Adjusted EBITDA to be ahead of market expectations[1] by c.10%.

Optima has continued to make strong progress against its strategic objectives and medium-term targets of £200 million revenue and £40 million adjusted EBITDA. The recent acquisition of PAM, which completed on 26 March 2026, positions the enlarged Group to capitalise on the growing market opportunity, whilst benefiting from significant operational and cost synergies which will help Optima achieve its medium-term EBITDA target.

The previously disclosed procurement matter has now been settled. Other operating income of £2.3 million was recognised in H1 FY26, and a further £2.4 million has been recognised in H2 FY26.

A full trading update will be made later in Q2 2026.

Jonathan Thomas, Chief Executive Officer, said: "Optima's strong financial performance in H2, ahead of market expectations, reflects the consistent progress we have continued to make against our strategic objectives. The recent transformational acquisition of PAM has further solidified Optima's position in the attractive and growing occupational health market. We look forward to increasing our presence in our core markets, alongside seeking new opportunities, as we continue to accelerate growth."

 

Enquiries

Optima Health

Jonathan Thomas, CEO

Heidi Giles, CFO

 

+44(0)3300085113

media@OptimaHealth.co.uk

Panmure Liberum Limited

Nominated Adviser and Corporate Broker

Emma Earl / Will Goode/ Mark Rogers

Rupert Dearden

 

+44 (0)20 3100 2000

 

Cavendish Capital Markets

Joint Broker

Geoff Nash/Ben Jeynes/George Lawson

Julian Morse/Michael Johnson/Nigel Birks

 

+ 44 (0)20 7220 0500

ICR Healthcare

UK Financial PR Adviser

Mary-Jane Elliott / Angela Gray / Lindsey Neville

optimahealth@icrinc.com

 

 

About Optima Health

Optima Health is the UK's leading provider of occupational health and wellbeing services, delivering clinically led, technology-driven solutions to organisations across the public and private sectors. With a team of more than 2,000 including 1,250 clinicians, Optima Health supports millions of employees and operates from a network of more than 50 clinics nationwide.

 In addition to its core UK market, Optima Health also operates in Ireland under Optima Health Ireland, providing occupational health services to clients nationwide.

 

For more information visit www.optimahealth.co.uk

 


[1] FY26 adjusted EBITDA market consensus £18.1 million

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBVVRNRUSARR
Date   Source Headline
11th Sep 20078:49 amRNSAudio Webcast
7th Sep 20078:48 amBUSOcean Power Technologies, Inc: Annual Meeting and Proxy Materials
7th Sep 20078:15 amRNSNotice of AGM
21st Aug 20077:01 amRNSNew Contract
21st Aug 20077:00 amBUSContract for First Powerbuoy at Reedsport, Oregon
17th Aug 20072:36 pmRNSAim Rule 26
30th Jul 20077:01 amRNSFinal Results
30th Jul 20077:00 amBUSOcean Power Technologies Announces Results for the Year Ended April 30, 2007
25th Jul 20079:49 amBUSOcean Power Technologies to Host Audio Webcast on Year-End Results
25th Jul 20079:17 amRNSAudio Webcast
23rd Jul 20077:01 amRNSNotice of Results
6th Jul 20079:47 amRNSAdditional Listing of Shares
2nd Jul 20077:01 amRNSGrid connection compliant
2nd Jul 20077:00 amBUSOPT's PowerBuoy Grid Connection Compliant with International Standards
29th Jun 20077:03 amRNSAdditional Listing of Shares
26th Jun 20077:02 amRNSAppointment of COO
26th Jun 20077:00 amBUSOPT Names Draper as Chief Operating Officer
22nd Jun 20079:45 amRNSDirector/PDMR Shareholding
7th Jun 20077:03 amRNSNew contract win
7th Jun 20077:00 amBUSOPT Wins New Contract with US Navy
18th May 20079:03 amRNSAdditional Listing of Shares
10th May 20078:00 amRNSFirst day of dealings
10th May 20078:00 amRNSCancel - Ocean Power Tech.
3rd May 20077:02 amRNSAdmission to CREST
2nd May 20078:25 amRNSSignificant Shareholder
1st May 20079:17 amBUSOcean Power Technologies Completes Initial Public Offering in The US
1st May 20078:40 amRNSCompletion of US IPO
25th Apr 20079:05 amRNSPricing of IPO in US
16th Apr 20077:02 amRNSReverse Stock Split Update
13th Apr 20072:00 pmRNSReverse Stock Split
10th Apr 20075:11 pmRNSS1 Amendment Filing
19th Mar 200712:24 pmRNSOPT S1 Amendment
19th Mar 200712:17 pmRNSNine month results
6th Mar 20077:03 amRNSDirector/PDMR Shareholding
22nd Feb 20078:01 amBUSAgreement for Development of Wave Power Park in Oregon
22nd Feb 20077:01 amRNSOPT signs agreement
20th Feb 20077:02 amRNSOPT awarded $1.2m
16th Feb 20074:49 pmRNSDirector/PDMR Shareholding
8th Feb 20074:55 pmRNSSchedule 1 - Ocean Power Tech
6th Feb 20077:01 amRNSS-1 Amendment
31st Jan 20074:03 pmRNSInterim Results
30th Jan 20075:48 pmBUSAward of Operation and Maintenance Contract for Wave Farm in Spain
30th Jan 20077:01 amRNSAward of Contract
24th Jan 20077:01 amRNSApplications for permits
15th Jan 20075:27 pmRNSResult of AGM
13th Dec 20067:02 amRNSAnnual Meeting and Proxy
13th Nov 20067:01 amRNSRegistration Filing Statement
13th Nov 20067:01 amRNSQuarter Results ended July 06
13th Nov 20067:00 amBUSOcean Power Technologies Announces Results for the Quarter Ended 31 July 2006
13th Nov 20067:00 amBUSOcean Power Technologies, Inc. Files Registration Statement for Initial Public Offering in US

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.